Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hans Hirsch and Nina Khanna.
Hans Hirsch
Connection Strength
1.098
Nina Khanna
  1. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss Med Wkly. 2021 08 02; 151:w20550.
    View in: PubMed
    Score: 0.240
  2. Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2021 02 24; 223(4):734-735.
    View in: PubMed
    Score: 0.233
  3. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures. J Med Virol. 2021 04; 93(4):2374-2384.
    View in: PubMed
    Score: 0.230
  4. Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2020 09 14; 222(8):1270-1279.
    View in: PubMed
    Score: 0.226
  5. Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J Intensive Care. 2021 Jan 18; 9(1):10.
    View in: PubMed
    Score: 0.058
  6. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.056
  7. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study. Am J Transplant. 2020 10; 20(10):2876-2882.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.